Clinical Trial: BPL-1357 Against H1N1 Influenza Virus Challenge

U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07215858) titled 'BPL-1357 Against H1N1 Influenza Virus Challenge' on Oct. 10.

Brief Summary: Background:

Influenza (flu) infections are a serious global health threat. Each year, between 3 and 5 million people get the flu, and up to 500,000 die from it. Current vaccines protect against seasonal flus, but broader vaccines are needed to protect against potential flu pandemics.

Objective:

To test an experimental flu vaccine.

Eligibility:

Healthy people aged 18 to 55 years.

Design:

The study will last 5 to 8 months and has 2 phases, A and B.

The study vaccine will be given either as a shot in the arm or as a nasal spray. Participants will receiv...